Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

C-Geranylated flavonoids from Paulownia tomentosa fruits with antimicrobial potential and synergistic activity with antibiotics

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F16%3A00463702" target="_blank" >RIV/61388963:_____/16:00463702 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/62157124:16170/16:43874123 RIV/62157124:16370/16:43874123 RIV/62157124:16810/16:43874123 RIV/75010330:_____/16:00011406

  • Výsledek na webu

    <a href="http://dx.doi.org/10.3109/13880209.2015.1103755" target="_blank" >http://dx.doi.org/10.3109/13880209.2015.1103755</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3109/13880209.2015.1103755" target="_blank" >10.3109/13880209.2015.1103755</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    C-Geranylated flavonoids from Paulownia tomentosa fruits with antimicrobial potential and synergistic activity with antibiotics

  • Popis výsledku v původním jazyce

    C-6-Geranylated flavonoids possess promising biological activities. These substances could be a source of lead compounds for the development of therapeutics. The study was designed to evaluate their antibacterial and antileishmanial activity. C-6-Geranylated flavanones were tested in micromolar concentrations against promastigote forms of Leishmaniabrazilensis, L. donovani, L. infantum, and L. panamensis against methicillin-resistant Staphylococcus aureus (MRSA); and synergistic potential with antibiotics was analyzed. IC50 values (after 72h) were calculated and compared with that of miltefosine. Flow cytometry and DNA fragmentation analysis were used the mechanism of the effect. Geranylated flavanones or epigallocatechin gallate were combined with oxacillin, tetracycline, and ciprofloxacin, and the effects of these two-component combinations were evaluated. Minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) were established (after 24h), the synergy was measured by the checkerboard titration technique, and the sums of the fractional inhibitory concentrations (Sigma FICs) were computed. 3-O-Methyl-5-O-methyldiplacone and 3-O-methyldiplacone showed good antileishmanial activities (IC50 8-42M). 3-O-Methyl-5-hydroxydiplacone activates the apoptotic death at leishmanias, the effect of 3-O-methyl-5-O-methyldiplacone has another mechanism. The test of the antibacterial activity showed good effects of 3-O-methyldiplacol and mimulone against MRSA (MIC 2-16g/mL), and in six cases, the results showed synergistic effects when combined with oxacillin. Synergistic effects were also found for the combination of epigallocatechin gallate with tetracycline or oxacillin. This work demonstrates anti-MRSA and antileishmanial potential of geranylated flavanones and uncovers their promising synergistic activities with antibiotics. In addition, the mechanism of antileishmanial effect is proposed.

  • Název v anglickém jazyce

    C-Geranylated flavonoids from Paulownia tomentosa fruits with antimicrobial potential and synergistic activity with antibiotics

  • Popis výsledku anglicky

    C-6-Geranylated flavonoids possess promising biological activities. These substances could be a source of lead compounds for the development of therapeutics. The study was designed to evaluate their antibacterial and antileishmanial activity. C-6-Geranylated flavanones were tested in micromolar concentrations against promastigote forms of Leishmaniabrazilensis, L. donovani, L. infantum, and L. panamensis against methicillin-resistant Staphylococcus aureus (MRSA); and synergistic potential with antibiotics was analyzed. IC50 values (after 72h) were calculated and compared with that of miltefosine. Flow cytometry and DNA fragmentation analysis were used the mechanism of the effect. Geranylated flavanones or epigallocatechin gallate were combined with oxacillin, tetracycline, and ciprofloxacin, and the effects of these two-component combinations were evaluated. Minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) were established (after 24h), the synergy was measured by the checkerboard titration technique, and the sums of the fractional inhibitory concentrations (Sigma FICs) were computed. 3-O-Methyl-5-O-methyldiplacone and 3-O-methyldiplacone showed good antileishmanial activities (IC50 8-42M). 3-O-Methyl-5-hydroxydiplacone activates the apoptotic death at leishmanias, the effect of 3-O-methyl-5-O-methyldiplacone has another mechanism. The test of the antibacterial activity showed good effects of 3-O-methyldiplacol and mimulone against MRSA (MIC 2-16g/mL), and in six cases, the results showed synergistic effects when combined with oxacillin. Synergistic effects were also found for the combination of epigallocatechin gallate with tetracycline or oxacillin. This work demonstrates anti-MRSA and antileishmanial potential of geranylated flavanones and uncovers their promising synergistic activities with antibiotics. In addition, the mechanism of antileishmanial effect is proposed.

Klasifikace

  • Druh

    J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

  • CEP obor

    FR - Farmakologie a lékárnická chemie

  • OECD FORD obor

Návaznosti výsledku

  • Projekt

    <a href="/cs/project/ED1.1.00%2F02.0068" target="_blank" >ED1.1.00/02.0068: CEITEC - central european institute of technology</a><br>

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2016

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Pharmaceutical Biology

  • ISSN

    1388-0209

  • e-ISSN

  • Svazek periodika

    54

  • Číslo periodika v rámci svazku

    8

  • Stát vydavatele periodika

    GB - Spojené království Velké Británie a Severního Irska

  • Počet stran výsledku

    10

  • Strana od-do

    1398-1407

  • Kód UT WoS článku

    000381024800011

  • EID výsledku v databázi Scopus

    2-s2.0-84955119969